Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Disclosure of interest: Financial support for this study was provided by Alnylam Pharmaceuticals and Biogen Poster Session II - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P771 - ESOC25-495 PREHOSPITAL DETECTION OF INTRACRANIAL HEMORRHAGE USING A PORTABLE GFAP DEVICE IN PATIENTS WITH ACUTE FOCAL NEUROLOGICAL DEFICITS OR REDUCED CONSCIOUSNESS TRANSPORTED BY EMERGENCY VEHICLES Iris Voka 1 , Love-Preet Kalra 1 , Sabina Zylyftari 1 , Mastura Ganji 1 , Deepak Bos 1 , Klodiana Meci 1 , Stephan Barthelmes 1 , Gregor Lichy 2,3 , Simon Schwarzach 4 , Till Frscher 5 , Dominik Mayer 5 , Jens Pluto 5 , Timo Breining 5 , Sebastian Luger 1,6 , Christian Foerch 1,6 1 Department of Neurology, RKH Klinikum, Ludwigsburg, Germany, 2 Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, RKH Klinikum, Ludwigsburg, Germany, 3 DRF Luftrettung Stuttgart, Stuttgart, Germany, 4 DRF Luftrettung Karlsruhe, Karlsruhe, Germany, 5 DRK Rettungsdienst Ludwigsburg, Ludwigsburg, Germany, 6 Department of Neurology, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany Background and Aims: Intracerebral hemorrhage(ICH) requires rapid diagnosis for optimal patient outcomes
May support healing of many different wounds, including tendon-to-bone healing and superior healing of damaged ligaments
Most patients see clear improvement by 48 hours, and swelling or stiffness generally ends between three and five days once the immune response stabilizes
+ Frequency depends on your deficiency level
US$ 20.58
US$ 25.51
US$ 21.00
US$ 27.36
US$ 29.86
US$ 29.25